Guggenheim Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.74M | Sell |
9,215
-2,416
| -21% | -$422K | 0.01% | 746 |
|
|
2025
Q4 | $1.98M | Buy |
11,631
+1,150
| +11% | +$176K | 0.01% | 677 |
|
|
2025
Q3 | $1.38M | Sell |
10,481
-41
| -0.4% | -$4.92K | 0.01% | 815 |
|
|
2025
Q2 | $1.12M | Sell |
10,522
-11,619
| -52% | -$1.26M | 0.01% | 847 |
|
|
2025
Q1 | $2.75M | Sell |
22,141
-2,610
| -11% | -$340K | 0.03% | 557 |
|
|
2024
Q4 | $3.05M | Sell |
24,751
-10,959
| -31% | -$1.29M | 0.02% | 536 |
|
|
2024
Q3 | $3.98M | Sell |
35,710
-11,500
| -24% | -$1.26M | 0.03% | 600 |
|
|
2024
Q2 | $5.04M | Buy |
47,210
+518
| +1% | +$57K | 0.04% | 514 |
|
|
2024
Q1 | $5.62M | Buy |
46,692
+1,371
| +3% | +$168K | 0.04% | 511 |
|
|
2023
Q4 | $5.57M | Sell |
45,321
-7,177
| -14% | -$896K | 0.04% | 497 |
|
|
2023
Q3 | $6.8M | Sell |
52,498
-4,314
| -8% | -$575K | 0.06% | 393 |
|
|
2023
Q2 | $7.04M | Buy |
56,812
+3,487
| +7% | +$469K | 0.06% | 414 |
|
|
2023
Q1 | $7.8M | Sell |
53,325
-1,239
| -2% | -$183K | 0.07% | 365 |
|
|
2022
Q4 | $8.69M | Buy |
54,564
+9,075
| +20% | +$1.33M | 0.08% | 331 |
|
|
2022
Q3 | $6.06M | Sell |
45,489
-3,687
| -7% | -$561K | 0.06% | 427 |
|
|
2022
Q2 | $7.67M | Buy |
49,176
+15,486
| +46% | +$2.38M | 0.06% | 383 |
|
|
2022
Q1 | $5.25M | Sell |
33,690
-46,777
| -58% | -$6.79M | 0.03% | 630 |
|
|
2021
Q4 | $10.3M | Buy |
80,467
+26,778
| +50% | +$3.52M | 0.05% | 422 |
|
|
2021
Q3 | $6.99M | Sell |
53,689
-4,137
| -7% | -$625K | 0.04% | 519 |
|
|
2021
Q2 | $10.3M | Sell |
57,826
-11,152
| -16% | -$1.93M | 0.06% | 392 |
|
|
2021
Q1 | $11.3M | Sell |
68,978
-13,446
| -16% | -$2.21M | 0.07% | 320 |
|
|
2020
Q4 | $13.6M | Buy |
82,424
+13,835
| +20% | +$2.06M | 0.09% | 241 |
|
|
2020
Q3 | $9.78M | Sell |
68,589
-12,884
| -16% | -$1.6M | 0.07% | 291 |
|
|
2020
Q2 | $8.99M | Buy |
81,473
+15,362
| +23% | +$1.7M | 0.07% | 297 |
|
|
2020
Q1 | $6.59M | Sell |
66,111
-14,716
| -18% | -$1.9M | 0.07% | 338 |
|
|
2019
Q4 | $12.1M | Buy |
80,827
+24,941
| +45% | +$3.39M | 0.09% | 265 |
|
|
2019
Q3 | $7.16M | Sell |
55,886
-2,252
| -4% | -$302K | 0.06% | 427 |
|
|
2019
Q2 | $8.29M | Sell |
58,138
-6,084
| -9% | -$818K | 0.07% | 358 |
|
|
2019
Q1 | $9.18M | Sell |
64,222
-16,601
| -21% | -$2.17M | 0.07% | 321 |
|
|
2018
Q4 | $10M | Sell |
80,823
-9,492
| -11% | -$1.41M | 0.08% | 261 |
|
|
2018
Q3 | $15.2M | Buy |
90,315
+58,563
| +184% | +$10.1M | 0.1% | 209 |
|
|
2018
Q2 | $5.47M | Buy |
+31,752
| New | +$5.19M | 0.04% | 661 |
|
|
2018
Q1 | – | Sell |
-34,423
| Closed | -$5.05M | – | 1018 |
|
|
2017
Q4 | $4.63M | Sell |
34,423
-10,009
| -23% | -$1.39M | 0.01% | 1083 |
|
|
2017
Q3 | $6.5M | Buy |
44,432
+10,688
| +32% | +$1.62M | 0.02% | 905 |
|
|
2017
Q2 | $5.25M | Sell |
33,744
-836
| -2% | -$128K | 0.01% | 989 |
|
|
2017
Q1 | $5.02M | Sell |
34,580
-8,155
| -19% | -$1.06M | 0.01% | 1019 |
|
|
2016
Q4 | $4.66M | Sell |
42,735
-3,333
| -7% | -$371K | 0.01% | 1047 |
|
|
2016
Q3 | $5.6M | Buy |
46,068
+13,367
| +41% | +$1.8M | 0.02% | 957 |
|
|
2016
Q2 | $4.62M | Sell |
32,701
-11,045
| -25% | -$1.63M | 0.01% | 1047 |
|
|
2016
Q1 | $5.71M | Sell |
43,746
-19,261
| -31% | -$2.4M | 0.02% | 917 |
|
|
2015
Q4 | $8.86M | Buy |
63,007
+11,493
| +22% | +$1.59M | 0.03% | 787 |
|
|
2015
Q3 | $6.84M | Buy |
51,514
+7,299
| +17% | +$1.26M | 0.02% | 908 |
|
|
2015
Q2 | $7.79M | Buy |
44,215
+8,755
| +25% | +$1.57M | 0.02% | 951 |
|
|
2015
Q1 | $6.13M | Buy |
35,460
+15,660
| +79% | +$2.69M | 0.01% | 1070 |
|
|
2014
Q4 | $3.24M | Buy |
19,800
+5,409
| +38% | +$898K | 0.01% | 1374 |
|
|
2014
Q3 | $2.31M | Sell |
14,391
-510
| -3% | -$78.4K | 0.01% | 1653 |
|
|
2014
Q2 | $2.19M | Sell |
14,901
-4,381
| -23% | -$608K | 0.01% | 1728 |
|
|
2014
Q1 | $2.67M | Buy |
19,282
+1,560
| +9% | +$235K | 0.01% | 1541 |
|
|
2013
Q4 | $2.24M | Sell |
17,722
-2,284
| -11% | -$236K | 0.01% | 1685 |
|
|
2013
Q3 | $1.84M | Buy |
+20,006
| New | +$1.61M | 0.01% | 1672 |
|
Other funds holding JAZZ
VPM
VCM
EC
Guggenheim Capital's JAZZ Position: Q1 2026 in Review
Guggenheim Capital reduced its Jazz Pharmaceuticals (JAZZ) stake by 21% in Q1 2026, selling an estimated $422K and leaving 9,215 shares worth $1.74M. The position accounts for 0.01% of the portfolio, ranked #746.
Guggenheim Capital first reported a position in JAZZ in Q3 2013 and has held it in 50 quarters since. The position peaked at $15.2M in Q3 2018. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Guggenheim Capital held 9,215 shares of Jazz Pharmaceuticals worth $1.74M as of Q1 2026.
- Guggenheim Capital sold 2,416 Jazz Pharmaceuticals shares in Q1 2026, an estimated $422K.
- Jazz Pharmaceuticals made up 0.01% of Guggenheim Capital's portfolio in Q1 2026, its #746 holding.
- Guggenheim Capital first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 50 quarters since.
- Guggenheim Capital's Jazz Pharmaceuticals position peaked at $15.2M in Q3 2018.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.